Unum Group $UNM Shares Purchased by Intech Investment Management LLC

Intech Investment Management LLC increased its position in shares of Unum Group (NYSE:UNM) by 22.1% during the second quarter, HoldingsChannel reports. The institutional investor owned 126,330 shares of the financial services provider’s stock after buying an additional 22,863 shares during the quarter. Intech Investment Management LLC’s holdings in Unum Group were worth $10,202,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Charles Schwab Investment Management Inc. boosted its holdings in shares of Unum Group by 4.8% in the first quarter. Charles Schwab Investment Management Inc. now owns 5,816,520 shares of the financial services provider’s stock valued at $473,814,000 after acquiring an additional 264,268 shares during the period. Geode Capital Management LLC boosted its stake in Unum Group by 7.0% during the 2nd quarter. Geode Capital Management LLC now owns 3,341,589 shares of the financial services provider’s stock worth $271,862,000 after purchasing an additional 219,076 shares during the period. Invesco Ltd. grew its position in Unum Group by 155.6% during the 1st quarter. Invesco Ltd. now owns 2,278,473 shares of the financial services provider’s stock worth $185,604,000 after purchasing an additional 1,387,139 shares during the last quarter. Allianz Asset Management GmbH increased its stake in Unum Group by 11.5% in the second quarter. Allianz Asset Management GmbH now owns 1,537,189 shares of the financial services provider’s stock valued at $124,143,000 after purchasing an additional 159,084 shares during the period. Finally, Nordea Investment Management AB increased its stake in Unum Group by 3.6% in the second quarter. Nordea Investment Management AB now owns 1,482,096 shares of the financial services provider’s stock valued at $119,235,000 after purchasing an additional 51,750 shares during the period. Hedge funds and other institutional investors own 86.57% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on the company. Wells Fargo & Company lowered their price target on Unum Group from $100.00 to $98.00 and set an “overweight” rating on the stock in a report on Wednesday, October 8th. Keefe, Bruyette & Woods reiterated an “outperform” rating and issued a $95.00 target price (down from $100.00) on shares of Unum Group in a research note on Thursday, July 31st. Barclays upped their price target on Unum Group from $92.00 to $95.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 8th. Weiss Ratings reiterated a “buy (b-)” rating on shares of Unum Group in a research report on Thursday. Finally, Morgan Stanley boosted their price objective on shares of Unum Group from $79.00 to $81.00 and gave the company an “equal weight” rating in a research note on Tuesday, October 7th. Two equities research analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, Unum Group presently has a consensus rating of “Moderate Buy” and a consensus target price of $94.67.

Unum Group Trading Down 0.1%

Shares of UNM stock opened at $76.96 on Friday. The business’s fifty day moving average price is $76.18 and its 200 day moving average price is $76.84. The firm has a market capitalization of $12.88 billion, a PE ratio of 9.21, a P/E/G ratio of 1.23 and a beta of 0.37. The company has a debt-to-equity ratio of 0.31, a current ratio of 0.30 and a quick ratio of 0.30. Unum Group has a 1-year low of $66.81 and a 1-year high of $84.48.

Unum Group (NYSE:UNM) last issued its earnings results on Monday, November 3rd. The financial services provider reported $2.09 EPS for the quarter, missing the consensus estimate of $2.15 by ($0.06). Unum Group had a return on equity of 13.44% and a net margin of 11.77%.The company had revenue of $3.25 billion for the quarter, compared to analysts’ expectations of $3.31 billion. During the same quarter in the previous year, the firm posted $2.13 earnings per share. Unum Group’s revenue for the quarter was up 5.0% on a year-over-year basis. Unum Group has set its FY 2025 guidance at EPS. As a group, sell-side analysts forecast that Unum Group will post 9.14 EPS for the current fiscal year.

Unum Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, November 14th. Shareholders of record on Friday, October 24th were given a dividend of $0.46 per share. This represents a $1.84 annualized dividend and a yield of 2.4%. The ex-dividend date was Friday, October 24th. Unum Group’s dividend payout ratio is presently 35.87%.

Insider Transactions at Unum Group

In other news, EVP Christopher W. Pyne sold 4,000 shares of Unum Group stock in a transaction that occurred on Friday, November 7th. The shares were sold at an average price of $78.04, for a total transaction of $312,160.00. Following the completion of the sale, the executive vice president directly owned 51,372 shares in the company, valued at approximately $4,009,070.88. This trade represents a 7.22% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.92% of the company’s stock.

Unum Group Company Profile

Unum Group, together with its subsidiaries, provides financial protection benefit solutions primarily in the United States, the United Kingdom, Poland, and internationally. It operates through Unum US, Unum International, Colonial Life, and Closed Block segment. The company offers group long-term and short-term disability, group life, and accidental death and dismemberment products; supplemental and voluntary products, such as individual disability, voluntary benefits, and dental and vision products; and accident, sickness, disability, life, and cancer and critical illness products.